Trademark: MENHIBRIX
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for MENHIBRIX
We do not have any records of a proof of use for MENHIBRIX at this moment.
Possible trademark infringements of MENHIBRIX
Basic Information about MENHIBRIX
- Serial Number
- 86082629
- Filing Date
- 04 Oct 2013
- Registration Number
- 4547097
- Registration Date
- 10 Jun 2014
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of MENHIBRIX on the blockchain with WikiTrademarks.io.
- First use of MENHIBRIX anywhere
- MENHIBRIX was first used on 04 Sep 2013 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 2
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns MENHIBRIX?
1. GlaxoSmithKline Biologicals S.A. Rixensart
2. GlaxoSmithKline Biologicals S.A. Rixensart
3. GlaxoSmithKline Biologicals S.A. Rixensart
Correspondent
- ANGELA L. WILSON
- GlaxoSmithKline
- Legal Global Trademarks, Mailstop: 5.5A
- Five Moore Drive
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io